Dolby Laboratories
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $304,995 | $395,630 | $346,706 | $307,024 |
Gross Profit | 264,676 | 350,899 | 303,498 | 267,505 |
EBITDA | 63,343 | 146,545 | 102,533 | 60,380 |
EBIT | 38,271 | 119,699 | 75,720 | 35,805 |
Net Income | 28,602 | 94,915 | 53,327 | 49,332 |
Net Change In Cash | 304,995 | 395,630 | 346,706 | 307,024 |
Free Cash Flow | 147,671 | 46,419 | 49,421 | 100,994 |
Cash | 669,394 | 594,282 | 643,845 | 701,893 |
Basic Shares | 94,518 | 95,515 | 96,518 | 96,846 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $1,349,130 | $1,273,721 | $1,009,182 | $1,253,793 |
Gross Profit | 1,188,998 | 1,133,225 | 892,168 | 1,112,433 |
EBITDA | 378,563 | 399,806 | 219,247 | 318,888 |
EBIT | 279,966 | 312,479 | 219,247 | 215,279 |
Net Income | 255,018 | 261,825 | 191,470 | 184,087 |
Net Change In Cash | 1,349,130 | 1,273,721 | 1,009,182 | 1,253,793 |
Cost of Revenue | -587,917 | |||
Free Cash Flow | 430,257 | 297,245 | 259,912 | 259,120 |
Cash | 701,893 | 577,752 | 817,966 | 628,371 |
Basic Shares | 97,479 | 97,325 | 97,588 | 101,983 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.43 |
2026-03-31 | $1.37 |
2025-12-31 | $1.06 |
2025-09-30 | $0.99 |